Sangon Biotech: difference between revisions
Diff·revision 18 → 19·11:48, 17 Sep 2025
Difference between revision 18 and revision 19 of Sangon Biotech. 4 lines changed; the page grew by 261 bytes.
| Revision 18 — 03:21, 23 Aug 2025 EndotoxinEd (talk) add the note that self-published material is usable only for what it states about itself 12,139 bytes +592 | Revision 19 — 11:48, 17 Sep 2025 StubSorterBot (talk) bot: sort category members 12,400 bytes +261 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | [https://sangonbio.com/ Go to the SGN catalogue →] | |
| + | 76 | ||
| 75 | == Reception == | 77 | == Reception == |
| 76 | The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring themes are catalogue breadth and the documentary standard of the laboratory-reagent lines, which submissions describe as following the conventions of the reagent trade rather than those of the research-compound trade.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 78 | The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring themes are catalogue breadth and the documentary standard of the laboratory-reagent lines, which submissions describe as following the conventions of the reagent trade rather than those of the research-compound trade.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 82 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | 84 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. |
| 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| + | 86 | ||
| + | 87 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| 84 | 88 | ||
| 85 | == Regulatory position and legal status == | 89 | == Regulatory position and legal status == |